Russell Investments Group
OBIO icon

Russell Investments Group’s Orchestra BioMed OBIO Stock Holding History

Russell Investments Group’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Buy
+3,187
New +$13K ﹤0.01% 3877
2025
Q3 		– Sell
-193
Closed -$517 – 4200
2025
Q2 		$517 Buy
+193
New +$563 ﹤0.01% 3741
2025
Q1 		– Sell
-125
Closed -$500 – 3855
2024
Q4 		$500 Sell
125
-198
-61% -$1.06K ﹤0.01% 3610
2024
Q3 		$1.66K Sell
323
-3,527
-92% -$23K ﹤0.01% 3407
2024
Q2 		$31.4K Buy
+3,850
New +$22.3K ﹤0.01% 2865
2023
Q4 		– Sell
-91
Closed -$794 – 3279
2023
Q3 		$794 Buy
+91
New +$612 ﹤0.01% 3360

Other funds holding OBIO

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Russell Investments Group's OBIO Position: Q2 2026 in Review

Russell Investments Group opened a new position in Orchestra BioMed (OBIO) in Q2 2026: 3,187 shares worth $13.8K. The stake represents ﹤0.01% of the portfolio and ranks #3877 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in OBIO as recently as Q2 2025.

Russell Investments Group first reported a position in OBIO in Q3 2023 and has held it in 6 quarters since. The position peaked at $31.4K in Q2 2024. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • Russell Investments Group held 3,187 shares of Orchestra BioMed worth $13.8K as of Q2 2026.
  • Orchestra BioMed was a new Russell Investments Group position in Q2 2026.
  • Orchestra BioMed made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3877 holding.
  • Russell Investments Group first reported a position in Orchestra BioMed in Q3 2023 and has held it in 6 quarters since.
  • Russell Investments Group's Orchestra BioMed position peaked at $31.4K in Q2 2024.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.